<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A growing body of evidence has shown a strong association between elevated plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) levels with <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and thrombotic complications </plain></SENT>
<SENT sid="1" pm="."><plain>Data available in literature also suggest a role of <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> in abdominal and thoracic <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic diseases</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In particular, <z:chebi fb="0" ids="17230">Hcy</z:chebi> was investigated in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and it was demonstrated that <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels were associated with the risk of severe cardiovascular manifestations or dissection </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="17230">Hcy</z:chebi> was significantly higher also in patients with <z:hpo ids='HP_0004953'>abdominal aortic aneurysms</z:hpo> and was associated with the size of <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>It remains to be elucidated if this association is causal or simply an effect of the disease </plain></SENT>
<SENT sid="5" pm="."><plain>A number of mechanisms may be evoked to explain these findings </plain></SENT>
<SENT sid="6" pm="."><plain>Studies in animal models demonstrated that <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> could induce marked remodelling of the extracellular matrix of the arterial wall by inducing <z:e sem="disease" ids="C1306863" disease_type="Disease or Syndrome" abbrv="">elastolysis</z:e> through the activation of metalloproteinases </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, <z:chebi fb="0" ids="17230">Hcy</z:chebi> may directly affect fibrillin-1 or collagen by interfering with intra- and/or inter-molecular <z:chebi fb="0" ids="48343">disulfide</z:chebi> bonds through <z:chebi fb="0" ids="48343">disulfide</z:chebi> exchange, or binding to free <z:chebi fb="0" ids="29917">sulphydryl groups</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Further studies are needed to confirm the role of <z:chebi fb="0" ids="17230">Hcy</z:chebi> in <z:e sem="disease" ids="C0003493" disease_type="Disease or Syndrome" abbrv="">aortic disease</z:e> and the usefulness of including <z:chebi fb="0" ids="17230">Hcy</z:chebi> determination in the clinical evaluation of these patients </plain></SENT>
</text></document>